A study of interval breast cancer within the NHS breast screening programme
Authors:
Open Access
- 1 February 2000
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 53 (2) , 140-146
Abstract
Aim —To define the biological nature and malignant potential of interval cancers presenting to a breast unit within the NHS breast screening programme. Methods —112 interval cancers were compared with matched, screen detected and symptomatic cancers in terms of their radiographic, histopathological, and immunohistochemical features. Results —Interval cancers, strictly defined, showed no characteristic radiographic pattern. In terms of size, vascular invasion, lymph node status, and prognosis they were intermediate between screen detected and symptomatic cancers. Within the interval cancers there was an excess of grade 1 and grade 3 tumours, and lesions with a high Ki67 index but immunohistochemistry otherwise failed to discriminate between the three groups. Inclusion of data from false negative “interval cancers” did not significantly alter the results. Conclusions —Interval cancers are more aggressive than screen detected cancers but in general less aggressive than symptomatic cancers. However, within a heterogeneous group, occasional interval cancers are exceptionally malignant.Keywords
This publication has 38 references indexed in Scilit:
- Expression of Metastasis-Associated Genes h-mts1 ( S100A4 ) and nm23 in Carcinoma of Breast Is Related to Disease ProgressionDNA and Cell Biology, 1998
- Interval carcinomas of the breast: A group with intermediate outcomeJournal of Surgical Oncology, 1996
- Histopathology and growth rate of interval breast carcinoma: Characterization of different subgroupsCancer, 1996
- Survival in interval breast cancer in the DOM screening programmeEuropean Journal of Cancer, 1995
- Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.American Journal of Roentgenology, 1994
- Interval cancer and survival in a randomized breast cancer screening trial in StockholmBreast Cancer Research and Treatment, 1992
- The biology and natural history of breast cancer from the screening perspectiveWorld Journal of Surgery, 1989
- Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.BMJ, 1988
- SURVIVAL IN BREAST CANCER DIAGNOSED BETWEEN MAMMOGRAPHIC SCREENING EXAMINATIONSThe Lancet, 1986
- Assessment of malignancy potential in so-called interval mammary carcinomasBreast Cancer Research and Treatment, 1985